LYRICA: payments to doctors
Payments that named LYRICA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $966K
- Providers
- 24,714
- Transactions
- 82,065
- Average per transaction
- $12
The per-transaction average — $12 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 24,714 providers the average total is $39, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $931,351 | 96.4% |
| Mylan Inc. | $32,002 | 3.3% |
| Pfizer Pharmaceuticals LLC | $1,804 | 0.2% |
| PBG Puerto RICO LLC | $997 | 0.1% |